Feed aggregator
Fluor Announces Retirement of Executive Chairman, David E. Constable, and Appointment of James T. (Jim) Hackett as Chairman of the Board
IRVING, Texas--(BUSINESS WIRE)--Fluor Corporation (NYSE: FLR) today announced that David E. Constable, Executive Chairman, will step down from the Board of Directors following the Annual Shareholders Meeting on May 6, 2026. James T. (Jim) Hackett, the company’s Lead Independent Director, will assume the role of Chairman of the Board on May 5, 2026. Constable’s connection to Fluor spans 44 years. He began his career with the company in 1982, advancing through a series of global leadership roles
Jefferies Discloses Facts About Western Alliance and Western Alliance’s Loan Solely Against First Brands Receivables
NEW YORK--(BUSINESS WIRE)--Jefferies Financial Group Inc. (NYSE: JEF) (“Jefferies”) announced today that it has posted the attached letter from Jefferies’ CEO and President in response to the lawsuit and public statements by Western Alliance Bank (“Western Alliance”) concerning Western Alliance’s loans against receivables of First Brands. The letter makes clear that, among other things, For over four years, Western Alliance made non-recourse loans in steadily increasing amounts to borrowers nam
Korn Ferry Announces Third Quarter Fiscal 2026 Results of Operations
LOS ANGELES--(BUSINESS WIRE)--Korn Ferry (NYSE: KFY), a global consulting firm, today announced third quarter fee revenue of $717.4 million. In addition, third quarter diluted earnings per share was $1.23 and adjusted diluted earnings per share was $1.28. “Our strong quarterly performance continues to reflect the evolution of our firm,” said Gary D. Burnison, CEO, Korn Ferry. “Today the world is enveloped by unprecedented levels of change – shifts in population, demographics and technological a
Dealings in Securities by Executive Directors of AngloGold Ashanti plc
LONDON & DENVER & JOHANNESBURG--(BUSINESS WIRE)--AngloGold Ashanti plc (the “Company”) (NYSE: AU; JSE: ANG) announces that Executive Directors, Alberto Calderon and Gillian Doran, have dealt in securities of the Company. Name of Executive Director Alberto Calderon Name of Company AngloGold Ashanti plc Date of transaction 6 March 2026 Nature of transaction Off-market receipt of vested shares under the 2023 Deferred Share Plan (DSP) Class of security Ordinary shares Number of securities 80,296 Pr
Adobe and Major League Baseball Expand Partnership to Power Next Generation Digital Fan Experiences
SAN JOSE, Calif. & NEW YORK--(BUSINESS WIRE)--Adobe (Nasdaq:ADBE)—the global technology leader that unleashes creativity, productivity and customer experiences through innovative tools and platforms—and Major League Baseball (MLB), North America’s most historic professional sports league, today announced a major expansion of their multi-year partnership. To drive the next generation of digital fan experiences, Adobe is providing industry-leading solutions for MLB’s marketing, product and conten
TazWorks Launches AI-Powered Decisioning to Accelerate and Improve Accuracy of Key Background-Screening Workflows
IRVINE, Calif.--(BUSINESS WIRE)-- #digitallending--TazWorks, a platform for background screening companies powered by MeridianLink announced the integration of Cerebrum Synapse for AI decisioning.
American Strategic Investment Co. Announces Release Date for Fourth Quarter and Full Year 2025 Results
NEW YORK--(BUSINESS WIRE)--American Strategic Investment Co. (NYSE: NYC) (“ASIC” or the “Company”) announced today it will release its financial results as of, and for the fourth quarter and year ended December 31, 2025, on Thursday March 26, 2026, before the New York Stock Exchange open. The Company will also host a webcast and conference call the same day at 11:00 a.m. ET to review results and provide commentary on business performance. Dial-in instructions for the conference call and the rep
Palliser Seeks to Establish Minority Shareholder Voice at LG Chem as Company Continues to Ignore Deep Valuation Discount
LONDON--(BUSINESS WIRE)--Palliser Capital (“Palliser”), a top 10 shareholder of LG Chem, Ltd (“LG Chem” or the “Company”) today published a comprehensive presentation to “Recharge LG Chem” in advance of the Company’s Ordinary General Meeting of Shareholders (“AGM”) on March 31, 2026 with important information for shareholders about how Palliser’s shareholder proposals will help LG Chem unlock its deep discount and lead South Korea’s corporate and economic reforms. James Smith, Founder and CIO o
Report: GCs Say They Are Bullish on Europe
MILAN & MUNICH & PARIS--(BUSINESS WIRE)--European law firm association ADVANT surveyed more than 800 GCs in France, Germany, Italy and the United States for a new report
BCS Investors Have Opportunity to Join Barclays PLC Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)---- $BCS--BCS Investors Have Opportunity to Join Barclays PLC Fraud Investigation with the Schall Law Firm
ELWT Investors Have Opportunity to Join Elauwit Connection, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)---- $ELWT--ELWT Investors Have Opportunity to Join Elauwit Connection, Inc. Fraud Investigation with the Schall Law Firm
EAF Investors Have Opportunity to Join GrafTech International Ltd. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)---- $EAF--EAF Investors Have Opportunity to Join GrafTech International Ltd. Fraud Investigation with the Schall Law Firm
BSX Investors Have Opportunity to Join Boston Scientific Corporation Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)---- $BSX--BSX Investors Have Opportunity to Join Boston Scientific Corporation Fraud Investigation with the Schall Law Firm
DINO Investors Have Opportunity to Join HF Sinclair Corporation Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)---- $DINO--DINO Investors Have Opportunity to Join HF Sinclair Corporation Fraud Investigation with the Schall Law Firm
BFAM Investors Have Opportunity to Join Bright Horizons Family Solutions Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)---- $BFAM--BFAM Investors Have Opportunity to Join Bright Horizons Family Solutions Inc. Fraud Investigation with the Schall Law Firm
RUN Investors Have Opportunity to Join Sunrun Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)---- $RUN--RUN Investors Have Opportunity to Join Sunrun Inc. Fraud Investigation with the Schall Law Firm
PRCT Investors Have Opportunity to Join PROCEPT BioRobotics Corporation Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)---- $PRCT--PRCT Investors Have Opportunity to Join PROCEPT BioRobotics Corporation Fraud Investigation with the Schall Law Firm
Phillips 66 Appoints Howard Ungerleider and Kevin Meyers to Board of Directors
HOUSTON--(BUSINESS WIRE)--Phillips 66 today announced that it has appointed Howard Ungerleider and Kevin Meyers to serve on the Company’s Board of Directors.
CRWV Deadline: Rosen Law Firm Urges CoreWeave, Inc. (NASDAQ: CRWV) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of securities of CoreWeave, Inc. (NASDAQ: CRWV) between March 28, 2025 and December 15, 2025. CoreWeave describes itself as an “an AI cloud computing company.” For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that CoreWeave, Inc. (NAS
Investor Notice: Robbins LLP Informs Investors of the Soleno Therapeutics, Inc. Class Action Lawsuit
SAN DIEGO--(BUSINESS WIRE)---- $SLNO #SolenoTherapeuticsInc--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Soleno Therapeutics (NASDAQ: SLNO) common stock between March 26, 2025 and November 4, 2025. Soleno is a pharmaceutical company focused on developing therapies for rare diseases. The Company’s only commercial product is diazoxide choline extended-release tablets (“DCCR”) for the treatment of hyperphagia in individuals afflicted with Prader-Wil
